FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2016/10/007344 [Registered on: 06/10/2016] Trial Registered Retrospectively
Last Modified On: 14/12/2019
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Medical Device 
Study Design  Randomized, Parallel Group, Placebo Controlled Trial 
Public Title of Study   Pain relieving strategies in chronic tension-type headache(CTTH)  
Scientific Title of Study   Effect of rTMS on central and peripheral pain modulation in chronic tension-type headache 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Bhawna Mattoo 
Designation  junior resident 
Affiliation  All India Institute of Medical Sciences 
Address  room no. 2026,Department of Physiology,Academic Block All India Institute of medical sciences(AIIMS)
room no. 2026,Department of Physiology,Academic Block All India Institute of medical sciences(AIIMS)
South
DELHI
110029
India 
Phone  09717460911  
Fax    
Email  bhawnamattoo@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Bhawna Mattoo 
Designation  junior resident 
Affiliation  All India Institute of Medical Sciences 
Address  room no. 2026,Department of Physiology,Academic Block All India Institute of medical sciences(AIIMS)
room no. 2026,Department of Physiology,Academic Block All India Institute of medical sciences(AIIMS)
South
DELHI
110029
India 
Phone  09717460911  
Fax    
Email  bhawnamattoo@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Renu Bhatia 
Designation  Assistant Professor 
Affiliation  All India Institute of Medical Sciences 
Address  Dr. Renu Bhatia, Assistant Professor, Dept. of Physiology, All India Institute of Medical Sciences, Ansari Nagar
room no. 2026,Department of Physiology,Academic Block All India Institute of medical sciences(AIIMS)
South
DELHI
110029
India 
Phone  01126596440  
Fax    
Email  renuaiims28@gmail.com  
 
Source of Monetary or Material Support  
All India Institute of Medical Sciences, New delhi 
 
Primary Sponsor  
Name  AIIMS New Delhi 
Address  All India Institute of Medical Sciences, Ansari Nagar, New Delhi-110029 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Bhawna Mattoo  Trascranial Magnetic Stimulation lab,Department of physiology  All India Institute of Medical Sciences, Ansari Nagar, New Delhi-110029 South DELHI
South
DELHI 
01126549311

bhawnamattoo@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
institute ethics committtee,All India Institute of Medical Sciences  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  chronic tension type headache,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  1. Sucrose challenge test 2. Repetitive transcranial magnetic stimulation(rTMS)  1. Sucrose 25 gm/100ml orally pre and post rTMS (4 weeks); 2. Non invasive transcranial magnetic stimulation 1.0Hz for 30min/day for five consecutive days/week) for 4 weeks 3.Patient will be followed up for pain status and anxiety scores for 6 months 
Comparator Agent  Healthy subjects; chronic tension type headache subjects  Normal healthy subjects and Chronic tension type headache subjects with age group between 18-50 years 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  50.00 Year(s)
Gender  Both 
Details  This study is a randomized, parallel group, placebo controlled trial to study the effect of transcranial
magnetic stimulation on pain modulation status in chronic tension-type headache patients. Primary outcomes will be
subjective and objectives assessment of pain, biochemical analysis before and after rTMS therapywhich will be given for four weeks/five consecutive days/week. 
 
ExclusionCriteria 
Details  Use of morphinomimetic drugs,Use of muscle relaxants H/o drug addiction H/o Hormonal therapy H/o vasodilator drugs H/o other pain relieving measure like yoga, acupuncture, acupressure etc. H/o ferromagnetic implants in head and neck regions, cardiac pacemakers H/o abnormal menstrual cycle, pregnancy, lactation
H/o seizure
H/o diabetes
H/o any peripheral neuropathy 
 
Method of Generating Random Sequence   Random Number Table 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
1.Decrease in VAS Pain rating by 50%
2.Improvement decrease in LH level in response to sucrose
challenge test which is deranged in CTTH patients
3.The improvement nociceptive flexion reflex/R-III threshold  
The assessment will be done at the beginning of the treatment and after the completion of 20 days of rTMS therapy  
 
Secondary Outcome  
Outcome  TimePoints 
Pain in CTTH is mediated by opioids
rTMS is effective therapy for treatment of CTTH
 
Outcome name:Oral sucrose challenge test,
25gm/100 ml, pre and post rTMS, Time points:6
months, 1 year
Outcome name: rTMS, 30 min/day/20 sessions,
Time points:4 weeks 
 
Target Sample Size   Total Sample Size="20"
Sample Size from India="20" 
Final Enrollment numbers achieved (Total)= "30"
Final Enrollment numbers achieved (India)="30" 
Phase of Trial   N/A 
Date of First Enrollment (India)   30/07/2015 
Date of Study Completion (India) 30/11/2016 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details   nil 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary   this study is a randomized ,parallel group,placebo controlled trial to study the effect of transcranial magnetic stimulation on pain modulation status in chronic tension type headache patients.Primary outcomes will besubjective and objective assessment of pain,biochemical analysis before and after rTMS therapy which will be given for four consecutive weeks for five days a week. 
Close